Detalhe da pesquisa
1.
Effectiveness, safety and impact of guselkumab on sexuality and perceived stigmatization in patients with psoriasis in routine clinical practice: Week 28 results from the prospective German multicentre G-EPOSS study.
J Eur Acad Dermatol Venereol
; 2024 Apr 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38602225
2.
Depression, a major comorbidity of psoriatic disease, is caused by metabolic inflammation.
J Eur Acad Dermatol Venereol
; 37(9): 1731-1738, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37184282
3.
Effectiveness, safety and quality-of-life effects of guselkumab and ustekinumab in patients with psoriasis: Week 104 results from the non-interventional, prospective, German multicentre PERSIST study.
J Eur Acad Dermatol Venereol
; 2023 Jul 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37462295
4.
Real-world evidence from the non-interventional, prospective, German multicentre PERSIST study of patients with psoriasis after 1 year of treatment with guselkumab.
J Eur Acad Dermatol Venereol
; 36(9): 1568-1577, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35569014
5.
Tildrakizumab efficacy and safety in patients with psoriasis and concomitant metabolic syndrome: post hoc analysis of 5-year data from reSURFACE 1 and reSURFACE 2.
J Eur Acad Dermatol Venereol
; 36(10): 1774-1783, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35460287
6.
Serum autoantibody reactivity in bullous pemphigoid is associated with neuropsychiatric disorders and the use of antidiabetics and antipsychotics: a large, prospective cohort study.
J Eur Acad Dermatol Venereol
; 36(11): 2181-2189, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-35796163
7.
Oral dimethyl fumarate induces changes within the peripheral neutrophil compartment of patients with psoriasis that are linked with skin improvement.
Br J Dermatol
; 185(3): 605-615, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33657656
8.
Calcipotriol/betamethasone dipropionate foam demonstrates comparable efficacy to clinical trial data in the real world, improves patient satisfaction and is cost-effective.
J Eur Acad Dermatol Venereol
; 35 Suppl 1: 28-34, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33619780
9.
ActiPso: definition of activity types for psoriatic disease: A novel marker for an advanced disease classification.
J Eur Acad Dermatol Venereol
; 35(10): 2027-2033, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34076926
10.
A multicentre open-label study of apremilast in palmoplantar pustulosis (APLANTUS).
J Eur Acad Dermatol Venereol
; 35(10): 2045-2050, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34077577
11.
Secukinumab treatment leads to normalization of quality of life and disease symptoms in psoriasis patients with or without prior systemic psoriasis therapy: the PROSE study results.
J Eur Acad Dermatol Venereol
; 35(2): 431-440, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-32426889
12.
Continued treatment with secukinumab is associated with high retention or regain of response.
Br J Dermatol
; 182(1): 67-75, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30972746
13.
Guselkumab is superior to fumaric acid esters in patients with moderate-to-severe plaque psoriasis who are naive to systemic treatment: results from a randomized, active-comparator-controlled phase IIIb trial (POLARIS).
Br J Dermatol
; 183(2): 265-275, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31705526
14.
Effects of secukinumab on metabolic and liver parameters in plaque psoriasis patients.
J Eur Acad Dermatol Venereol
; 34(3): 533-541, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-31599476
15.
Baseline characteristics of patients with moderate-to-severe psoriasis according to previous systemic treatment exposure: the PROSE study population.
J Eur Acad Dermatol Venereol
; 34(11): 2548-2556, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32239541
16.
Long-term follow-up of 22 psoriatic patients treated with ixekizumab after failure of secukinumab.
Dermatol Online J
; 26(1)2020 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32155021
17.
Long-term follow-up of 22 psoriatic patients treated with ixekizumab after failure of secukinumab.
Dermatol Online J
; 26(2)2020 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32239902
18.
Clinical and molecular response to dupilumab treatment in pediatric atopic dermatitis: Results of the German TREATkids registry.
Allergy
; 2024 May 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38712730
19.
The genetic basis for most patients with pustular skin disease remains elusive.
Br J Dermatol
; 178(3): 740-748, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28887889
20.
Small dense LDL cholesterol in human subjects with different chronic inflammatory diseases.
Nutr Metab Cardiovasc Dis
; 28(11): 1100-1105, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30143407